Flachskampf Frank A, Baron Tomasz
Department of Medical Sciences, Cardiology and Clinical Physiology, Uppsala University Hospital, Uppsala University, 751 85 Uppsala, Sweden.
Uppsala Clinical Research Center, Uppsala University, 752 36 Uppsala, Sweden.
J Clin Med. 2022 Oct 20;11(20):6201. doi: 10.3390/jcm11206201.
Heart failure is becoming the central problem in cardiology. Its recognition, differential diagnosis, and the monitoring of therapy are intimately coupled with cardiac imaging. Cardiac imaging has witnessed an explosive growth and differentiation, with echocardiography continuing as the first diagnostic step; the echocardiographic exam itself has become considerably more complex than in the last century, with the assessment of diastolic left ventricular function and strain imaging contributing important information, especially in heart failure. Very often, however, echocardiography can only describe the fact of functional impairment and morphologic remodeling, whereas further clarification of the underlying disease, such as cardiomyopathy, myocarditis, storage diseases, sarcoidosis, and others, remains elusive. Here, cardiovascular magnetic resonance and perfusion imaging should be used judiciously to arrive as often as possible at a clear diagnosis which ideally enables specific therapy.
心力衰竭正成为心脏病学的核心问题。其识别、鉴别诊断以及治疗监测都与心脏成像密切相关。心脏成像经历了爆发式的发展与分化,超声心动图仍是首要的诊断步骤;超声心动图检查本身比上世纪复杂得多,对左心室舒张功能和应变成像的评估提供了重要信息,尤其是在心力衰竭方面。然而,超声心动图常常只能描述功能损害和形态重塑的事实,而对于诸如心肌病、心肌炎、贮积病、结节病等潜在疾病的进一步明确诊断仍然困难。在此,应明智地使用心血管磁共振成像和灌注成像,尽可能明确诊断,理想情况下实现特异性治疗。